Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD.

Journal: Kidney medicine
Published Date: Sep 10, 2019

Abstract

RATIONALE & OBJECTIVE: The accuracy of glycated hemoglobin (HbA) level for assessment of glycemic control in patients with chronic kidney disease (CKD) is uncertain. This study assessed the accuracy of HbA level using continuous glucose monitoring.

Authors

  • Lubaina Presswala
    Divisions of Nephrology and Endocrinology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.
  • Susana Hong
    Divisions of Nephrology and Endocrinology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.
  • Yael Harris
    Divisions of Nephrology and Endocrinology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.
  • Isabela Romao
    Divisions of Nephrology and Endocrinology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.
  • Meng Zhang
    College of Software, Beihang University, Beijing, China.
  • Kenar D Jhaveri
    Department of Medicine, Norwell Health, Manhasset, NY, USA.
  • Vipul Sakhiya
    Divisions of Nephrology and Endocrinology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.
  • Steven Fishbane
    Divisions of Nephrology and Endocrinology, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals